Consumer

By Jonah Comstock 03:43 pm February 20, 2020
Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor companies, Abbott and Dexcom. Both involve the Insulet’s Omnipod Horizon Automated Insulin Delivery System which uses a tubeless, wearable “Pod” to deliver insulin for 72 hours at a time. Abbott and Insulet have partnered to offer a new integrated digital health platform that will...
By Laura Lovett 03:50 pm February 19, 2020
Amazon employees and their families living in Seattle will now have access to tech-enabled Amazon Care, CNBC first reported. This comes roughly five months after the news emerged that the company was planning this rollout.  Like many services on the market, the tech giant will be offering face-to-face and virtual care options.  Patients will be able to access care through multiple channels...
By Laura Lovett 10:54 am February 18, 2020
The last month has been tough going for the consumer genomics industry with frontrunners 23andMe and Ancestory.com both announcing massive layoffs. However, new kid on the block Nebula Genomics is launching a consumer product today that will offer users whole genome sequencing for $299.  “We hope to really revitalize the whole space by making whole genome sequencing affordable, providing more...
By Laura Lovett 01:31 pm February 13, 2020
Direct-to-consumer virtual health company Ro launched a new health information platform dubbed Health Guide.  Currently the platform covers sexual health, hair loss, weight management, diabetes, and men’s health.  However, a representative from the company said that in the future, the plan is to expand the offerings to not only cater to male users, and to include more conditions.  The company,...
By Sophie Porter 06:55 am February 12, 2020
A study published in the BMJ has advised against the use of apps to assess the risk of skin cancer. Primarily targeted at catching early-stage melanoma by photographing suspicious skin lesions on a smartphone, the apps were found to be subject to “poor and variable performance”, in spite of one having gained CE marking. The discrepancy has led the authors to condemn the European regulatory...
By Dave Muoio 04:08 pm February 11, 2020
The accuracy of wearables employing photoplethysmography (PPG)-based heart rate sensors may vary significantly between specific devices and activity types, but these sensors’ performances do not appear to be significantly affected by the skin tone of the wearer, according to a new study published in NPJ Digital Medicine. The investigation, conducted by Duke University researchers among 53...
By Laura Lovett 01:55 pm February 5, 2020
Facebook is looking to curb misinformation about the ongoing coronavirus outbreak by removing false claims and conspiracy theories about the disease posted on its social media platforms.  In a recent blog post, the company announced that it is working with a network of third-party fact checkers to review information. If a piece of information is rated as false, the company pledges to limits its...
By Dave Muoio and Laura Lovett 11:32 am January 29, 2020
A new menopause health service has launched in California that offers women remote consultations and, for the first time, mail-order prescriptions of menopause hormone replacement therapies. Called CurieMD, the telemedicine platform offers consumers video consultation with a board-certified midlife health practitioners (free at launch, and $39 for follow-up appointments). Should that practitioner...
By MobiHealthNews 02:27 pm January 28, 2020
Unfortunately for us, MobiHealthNews doesn’t have a crystal ball (it would be darn useful for getting scoops). But we do have more than a decade’s worth of experience tracking the emergence of this space and we spend a lot of our time talking to smart people with industry experience and opinions of their own.  As we enter into a new decade in 2020, your MobiHealthNews staff has put our heads...
By Dave Muoio 01:40 pm January 27, 2020
Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s disease symptoms. By now targeting the internal globus pallidus alongside the subthalamic nucleus and ventral intermediate nucleus, the company says that its system “is now the only directional DBS...